Peter J. Pitts

Peter J. Pitts is president of the Center for Medicine in the Public Interest and a former FDA Associate Commissioner

  • Peter J. Pitts is President of the Center for Medicine in the Public Interest and a former FDA Associate Commissioner.

    MedCitizens

    340B drug discount program: Stop the abuse

    Some major American healthcare providers are padding their bottom lines by exploiting a federal program […]

    / Sep 9, 2013 at 11:34 AM
  • MedCitizens

    AD Hoc

    We should all pay attention to our nomenclature. It’s not about “conflict of interest” — […]

    / Jan 31, 2011 at 11:58 AM
  • MedCitizens

    Fat, drunk, stupid… and uninsured

    Yes Virginia, there is an interstate commerce clause. And there may yet be coal in […]

    / Dec 21, 2010 at 11:59 AM
  • MedCitizens

    An Obama tax credit to boost biopharma, R&D

    Obama’s proposal would allow companies to take a 17 percent deduction above 50 percent of R&D costs. Research and development are at the heart of America’s most vibrant industries. Case in point: The biopharmaceutical sector. Biopharma innovation is usually noteworthy for saving lives. Three years after introducing the first antiretroviral treatments, AIDS deaths dropped 70 percent, and new pharmaceuticals are largely responsible for cutting cancer death rates in half .

    / Sep 28, 2010 at 1:36 PM